Literature DB >> 9496261

Immunocytochemical analysis of the synaptic proteins SNAP-25 and Rab3A in human pituitary adenomas. Overexpression of SNAP-25 in the mammmosomatotroph lineages.

G Majó1, I Ferrer, J Marsal, J Blasi, F Aguado.   

Abstract

SNAP-25 and Rab3A were originally identified as synaptic proteins involved in neuronal membrane traffic. Recently, both proteins have been detected in several mammalian endocrine cell types and have been proposed as essential components of the exocytotic pathway in neuroendocrine cells. In this study, the expression of SNAP-25 and Rab3A was analysed in biopsied human anterior pituitary tumours (21 cases) by immunocytochemical methods. No differences in Rab3A immunoreactivity were observed between tumour and normal pituitary cells. Strong SNAP-25 immunoreactivity was detected in tumour cells of prolactinomas (n = 3). Several growth hormone (GH)/prolactin (PRL) tumours also displayed intense SNAP-25 immunolabelling (n = 3), whereas the remaining GH-secreting adenomas (n = 4) exhibited moderate to weak SNAP-25 immunoreactivity. In contrast, SNAP-25 near-background immunostaining was observed in tumour cells of adrenocorticotrophic hormone (ACTH)-secreting tumours (n = 4) and non-secreting tumours (n = 7), as well as in normal pituitary cells. Since SNAP-25 and Rab3A have been shown to be involved in exocytotic events in rodent endocrine cells, overexpression of SNAP-25 protein in PRL and GH/PRL tumour cells might be implicated in the mechanism of exocytosis of the neoplastic human mammosomatotroph lineages.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9496261     DOI: 10.1002/(SICI)1096-9896(199712)183:4<440::AID-PATH953>3.0.CO;2-#

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  9 in total

Review 1.  Classic and recent special stains used in differential diagnosis of endocrine tumors.

Authors:  G Bussolati; M Volante; M Papotti
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 2.  Practical markers used in the diagnosis of neuroendocrine tumors.

Authors:  Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 3.  Endocrine pathology in translational medicine: an overview of current and future prospects.

Authors:  Robert Yoshiyuki Osamura; Nobue Kumaki; Hiroshi Kajiwara; Noboru Egashira; Syunsuke Miyai; Susumu Takekoshi; Masanori Yasuda; Shinobu Umemura
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 4.  Mechanisms of storage and exocytosis in neuroendocrine tumors.

Authors:  Manfred Gratzl; Martin Breckner; Christian Prinz
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

5.  Neuroendocrine marker expression in thyroid epithelial tumors.

Authors:  F Satoh; S Umemura; M Yasuda; R Y Osamura
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

6.  D53 is a novel endosomal SNARE-binding protein that enhances interaction of syntaxin 1 with the synaptobrevin 2 complex in vitro.

Authors:  Véronique Proux-Gillardeaux; Thierry Galli; Isabelle Callebaut; Anatoly Mikhailik; Georges Calothy; Maria Marx
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

Review 7.  Gene expression in prolactinomas: a systematic review.

Authors:  Justin Seltzer; Thomas C Scotton; Keiko Kang; Gabriel Zada; John D Carmichael
Journal:  Pituitary       Date:  2016-02       Impact factor: 4.107

8.  Effect of hypothyroidism on synaptosomal-associated protein of 25 kDa and syntaxin-1 expression in adenohypophyses of rat.

Authors:  J L Quintanar; E Salinas
Journal:  J Endocrinol Invest       Date:  2002-10       Impact factor: 4.256

9.  Proteomic Profiling of Retinoblastoma-Derived Exosomes Reveals Potential Biomarkers of Vitreous Seeding.

Authors:  Angela Galardi; Marta Colletti; Chiara Lavarello; Virginia Di Paolo; Paolo Mascio; Ida Russo; Raffaele Cozza; Antonino Romanzo; Paola Valente; Rita De Vito; Luisa Pascucci; Hector Peinado; Angel M Carcaboso; Andrea Petretto; Franco Locatelli; Angela Di Giannatale
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.